| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.38 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.34 | 1e-08 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.27 | 2e-09 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.24 | 0.1 |